Company: PGEN
Filing Date: 2025-04-28
Form Type: 10-K/A
Source: 0001356090-25-000011
Chunk: 24

Company: PRECIGEN, INC.
Filing Date: 2025-04-28
Form: 10-K/A
Chunk 24
---
 and, subsequently, with members of the Board and the Compensation Committee’s independent compensation consultant, recommended to the Board the approval of the operational performance goals at 100% of target and of the clinical and financial performance goals at 100% of target.

For non-Chief Executive Officer NEO’s individual performance, all individuals were considered to have met their individual goals, with certain NEOs performing above expectations. Mr. Thomasian was awarded an additional 10% of his target bonus based on his leadership in raising additional capital during 2024. Mr. Shah was awarded an additional 25% of his target bonus based on his direct involvement in preparing, reviewing and submitting the BLA in 2024 along with his exemplary service to the Company through his involvement in other aspects of the Company’s day-to-day operations including supporting the capital raises in 2024 and his leadership in the Company’s manufacturing preparedness. Mr. Tennant was awarded an

<div align='center'>14</div>

additional 2% of his target bonus based on his leadership in building the Company’s commercial operations. Taking into consideration the continued focus on enhanced equity ownership by our executives, as well as cash preservation, the Compensation Committee also approved the short-term incentive bonuses to be paid 100% in RSUs scheduled to vest in May 2025 based on the grant date fair market value of the Company’s shares, as reflected in the table below.

| Name                |     | Annual Target  Bonus (% of 
 Base Salary)               |     |   |     | Total Value of  Target Bonus 
 ($)                          |           |     |    |     | Aggregate Achievement 
 Percentage of  Target 
 (%)                   |     | Actual Cash  Payment 
 ($)                  |   |     | RSUs    
 Granted |           |     | Total Value of 
 Actual Bonus   |           |
|:--------------------|:----|:---------------------------|----:|:--|:----|:-----------------------------|----------:|:----|---:|:----|:----------------------|:----|:---------------------|:--|:----|:--------|----------:|:----|:---------------|----------:|
| Dr. Helen Sabzevari |     |                            | 150 | % |     | $                            | 1,500,000 |     |    |     | 100%                  |     | $                    | — |     |         | 1,079,137 |     | $              | 1,500,000 |
|